Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Beule, Dieter Dr. (1) Blüthgen, Nils (1) Bunse, Mario Dr. (3) Chen, Wei Prof. Dr. (2) Daumke, Oliver Prof. Dr. (2) Dittmar, Gunnar Dr. (1) Edes, Inan Dr. (1) Fälber, Katja Dr. (1) Hammes-Lewin, Annette Dr. (1) Heinemann, Udo Prof. Dr. (1) Hirsekorn, Antje (1) Hübner, Norbert Prof. Dr. (1) Ivics, Zoltan Dr. (1) Izsvak, Zsuzsanna Dr. (2) Kammertöns, Thomas Dr. (2) Kettenmann, Helmut Prof. Dr. (1) Kieback, Elisa Dr. (2) Klußmann, Enno PD Dr. (1) Kobelt, Dennis Dr. (1) Ku, Min-Chi Dr. (1) Landthaler, Markus Prof. Dr. (2) Lewin, Gary Prof. Dr. (1) Lorenz, Felix Dr. (1) Lusatis, Simone (1) Mathas, Stephan Dr. (6) Niendorf, Thoralf Prof. Dr. (1) Obermayer-Wasserscheid, Benedikt Dr. (1) Ohler, Uwe Prof. Dr. (2) Panakova, Daniela Dr. (1) Patone, Giannino Dr. (1) Rajewsky, Klaus Prof. Dr. (1) Rocks, Oliver Dr. (2) Roske, Yvette Dr. (1) Scheidereit, Claus Prof. Dr. (1) Selbach, Matthias Prof. Dr. (10) Uckert, Wolfgang Prof. Dr. (12) Waiczies, Helmar Dr. (1) Waiczies, Sonia Dr. (1) Wanker, Erich Prof. Dr. (1) Wolf, Susanne Dr. (1) Wyler, Emanuel Dr. (1) Zauber, Henrik Dr. (3) Zühlke, Kerstin Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (5) (-) Daniel, Peter Prof. Dr. (1) (-) Janz, Martin Dr. (5) (-) Leisegang, Matthias Dr. (3) (-) Wollert-Wulf, Brigitte (2) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (12) 2004 (10) 2005 (12) (-) 2006 (5) 2007 (7) 2008 (8) 2009 (5) 2011 (9) 2013 (13) 2014 (6) 2015 (7) (-) 2016 (6) 2017 (10) 2018 (5) 2019 (6) 2020 (5) 2021 (7) 2023 (3) (-) Biology of Malignant Lymphomas (5) Genetics and Genomics of Cardiovascular Diseases (1) Immune Regulation and Cancer (1) (-) Molecular Cell Biology and Gene Therapy (4) (-) Molecular Immunology and Gene Therapy (5) Translational Oncology of Solid Tumors (1) 11 Results: Active Filter: Blankenstein, Thomas Prof. Dr.Daniel, Peter Prof. Dr.Janz, Martin Dr.Leisegang, Matthias Dr.Wollert-Wulf, BrigitteBiology of Malignant LymphomasMolecular Cell Biology and Gene TherapyMolecular Immunology and Gene Therapy20062016 Sort: Result score Newest to oldest Oldest to newest October 17, 2016 / J Exp Med Preventing tumor escape by targeting a post-proteasomal trimming independent epitope A. Textor K. Schmidt P.M. Kloetzel B. Weißbrich C. Perez J. Charo K. Anders J. Sidney A. Sette T.N.M. Schumacher C. Keller D.H. Busch U. Seifert T. Blankenstein July 22, 2016 / PLoS ONE Interleukin-7 modulates anti-tumor CD8+ T cell responses via its action on host cells K. Deiser D. Stoycheva U. Bank T. Blankenstein T. Schüler June 01, 2016 / Clin Cancer Res Eradication of large solid tumors by gene therapy with a T cell receptor targeting a single cancer-specific point mutation M. Leisegang B. Engels K. Schreiber P.Y. Yew K. Kiyotani C. Idel A. Arina J. Duraiswamy R.R. Weichselbaum W. Uckert Y. Nakamura H. Schreiber May 03, 2016 / Proc Natl Acad Sci U S A Canonical NF-κB signaling is uniquely required for the long-term persistence of functional mature B cells E. Derudder S. Herzog V. Labi T. Yasuda K. Köchert M. Janz A. Villunger M. Schmidt-Supprian K. Rajewsky April 07, 2016 / Nat Biotechnol Receptor combinations hone T-cell therapy T. Blankenstein March 01, 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein November 01, 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert May 15, 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas April 01, 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel March 15, 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou Pagination Current page 1 Page 2 Next page Next › Last page Last »
October 17, 2016 / J Exp Med Preventing tumor escape by targeting a post-proteasomal trimming independent epitope A. Textor K. Schmidt P.M. Kloetzel B. Weißbrich C. Perez J. Charo K. Anders J. Sidney A. Sette T.N.M. Schumacher C. Keller D.H. Busch U. Seifert T. Blankenstein
July 22, 2016 / PLoS ONE Interleukin-7 modulates anti-tumor CD8+ T cell responses via its action on host cells K. Deiser D. Stoycheva U. Bank T. Blankenstein T. Schüler
June 01, 2016 / Clin Cancer Res Eradication of large solid tumors by gene therapy with a T cell receptor targeting a single cancer-specific point mutation M. Leisegang B. Engels K. Schreiber P.Y. Yew K. Kiyotani C. Idel A. Arina J. Duraiswamy R.R. Weichselbaum W. Uckert Y. Nakamura H. Schreiber
May 03, 2016 / Proc Natl Acad Sci U S A Canonical NF-κB signaling is uniquely required for the long-term persistence of functional mature B cells E. Derudder S. Herzog V. Labi T. Yasuda K. Köchert M. Janz A. Villunger M. Schmidt-Supprian K. Rajewsky
March 01, 2016 / J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein
November 01, 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
May 15, 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
April 01, 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
March 15, 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
